Evaluation of Gut-Related Well-Being and Mood Effects of a Daily Nutritional Food Ingredient From the Co-Fermentation of Fungal Mycelium (Pleurotus Pulmonarius) and Microalgae (Chlorella Vulgaris)
Recruiting now · Not applicable · Has a placebo group
Conditions studied: Gastrointestinal Discomfort, Digestive Well Being, Gut-related Symptoms
In brief
The purpose of the study is to evaluate the gut-related well-being and mood effects of a food ingredient obtained from the co-fermentation of oyster mushroom mycelium (Pleurotus pulmonarius), microalgae (Chlorella vulgaris), and bamboo fibre in healthy adults (aged 18+) experiencing minor gastrointestinal discomfort during an intervention period of 30 days. The participants will be allocated into two unbalanced groups to determine relationships between the measurable outcomes and the dose levels at three different time points: start of the study (baseline), 15 days (middle), and 30 days (end-point), during which participants will be asked to complete GSRS and POMS-2-SF questionnaire
Key facts
- Study ID
- NCT07407777
- Run by
- Koralo GmbH
- People needed
- 80
- Starts
- 2026-01-19
- Expected to finish
- 2026-05-19
- Last updated by the study team
- 2026-02-12
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Adults aged 18 years or older
- Generally healthy individuals
- Experience minor, non-clinical gastrointestinal discomfort at least twice per week for ≥3 months
- Willing to consume the study product once daily for 30 days
- Able to dissolve and consume the powdered product in a beverage
- Able to read, understand, and complete electronic questionnaires in English
- Access to a smartphone or computer for study participation
- Provide electronic informed consent
You may not qualify if…
- Diagnosed gastrointestinal disease (e.g., IBS, IBD, GERD requiring medication)
- Use of medications affecting gastrointestinal function or mood within the past 30 days
- Initiation of new gut-, immune-, or mood-related supplements within 15 days prior to study start
- Known allergy or sensitivity to study product components
- Pregnancy or breastfeeding
- Major chronic medical condition that could interfere with study participation or data interpretation
- Participation in another interventional clinical study within the past 30 days
- Inability or unwillingness to comply with study procedures
Where it is running
- Alethios, Inc. — San Francisco, California, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.